Rchr
J-GLOBAL ID:202001009784334604   Update date: Oct. 22, 2024

Tani Hideaki

タニ ヒデアキ | Tani Hideaki
Affiliation and department:
Job title: 共同研究員
Research theme for competitive and other funds  (2):
  • 2022 - 2025 新たな治療法の開発に向けた治療抵抗性うつ病の神経基盤の解明:AMPA-PET研究
  • 2022 - 2025 Elucidating mechanisms of antidepressant effects of ketamine for treatment-resistant depression: an AMPA PET study
Papers (29):
  • Mai Hatano, Waki Nakajima, Hideaki Tani, Hiroyuki Uchida, Tomoyuki Miyazaki, Tetsu Arisawa, Yuuki Takada, Sakiko Tsugawa, Akane Sano, Kotaro Nakano, et al. Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography. Molecular psychiatry. 2024
  • Fumihiko Ueno, Mutsuki Sakuma, Shinichiro Nakajima, Sakiko Tsugawa, Ryo Ochi, Hideaki Tani, Yoshihiro Noda, Ariel Graff-Guerrero, Hiroyuki Uchida, Masaru Mimura, et al. Acetaldehyde-mediated increase in glutamatergic and N-acetylaspartate neurometabolite levels in the midcingulate cortex of ALDH2*1/*2 heterozygous young adults: A 1H-MRS study with an alcohol clamp technique. Alcohol: Clinical and Experimental Research. 2023
  • Yohei Ohtani, Keisuke Asano, Fumihiko Ueno, Ryosuke Den, Hiroki Hisae, Mitsuru Kimura, Sachio Matsushita, Takahito Uchida, Hideaki Tani, Shinichiro Nakajima, et al. New-onset addictions in patients with alcohol dependence: A cross-sectional study. Drug and alcohol dependence. 2023. 252. 110966-110966
  • Yumi Aoki, Yoshikazu Takaesu, Kentaro Matsui, Takahiro Tokumasu, Hideaki Tani, Yoshiteru Takekita, Tetsufumi Kanazawa, Taishiro Kishimoto, Seiichiro Tarutani, Naoki Hashimoto, et al. Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia. Neuropsychopharmacology reports. 2023. 43. 3. 391-402
  • Tsuyoshi Eiro, Tomoyuki Miyazaki, Mai Hatano, Waki Nakajima, Tetsu Arisawa, Yuuki Takada, Kimito Kimura, Akane Sano, Kotaro Nakano, Takahiro Mihara, et al. Dynamics of AMPA receptors regulate epileptogenesis in patients with epilepsy. Cell reports. Medicine. 2023. 4. 5. 101020-101020
more...
MISC (5):
  • 稲田健, 金沢徹文, 岸本泰士郎, 竹内啓善, 嶽北佳輝, 谷英明, 樽谷精一郎, 徳増卓宏, 橋本直樹, 松井健太郎. 向精神薬の適切な継続・減量・中止等の精神科薬物療法の出口戦略の実践に資する研究 マニュアル作成/統合失調症-抗精神病薬に関する研究. 向精神薬の適切な継続・減量・中止等の精神科薬物療法の出口戦略の実践に資する研究 令和元年度 総括・分担研究報告書(Web). 2020
  • H. Tani, T. Suzuki, S. Nakajima, T. Koizumi, M. Mimura, H. Uchida. AMPA receptors in schizophrenia: a systematic review of postmortem studies on receptor subunit expression and binding. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017. 27. S758-S758
  • Hideaki Tani, Takefumi Suzuki, Shinichiro Nakajima, Masaru Mimura, Hiroyuki Uchida. AMPA RECEPTOR SUBUNIT EXPRESSION AND RECEPTOR BINDING IN PATIENTS WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW OF POSTMORTEM STUDIES. SCHIZOPHRENIA BULLETIN. 2017. 43. S247-S247
  • Saeko Ikai, T. Suzuki, J. Saruta, K. Tsukinoki, H. Tani, N. Nagai, Ryosuke Kitahata, Ai Ohtani, Aki Endo, Y. Fujii, et al. EFFECTS OF WEEKLY ONE-HOUR HATHA YOGA THERAPY ON RESILIENCE AND STRESS LEVELS IN SCHIZOPHRENIA: A RANDOMIZED CONTROLLED EIGHT-WEEK TRIAL. SCHIZOPHRENIA BULLETIN. 2015. 41. S315-S316
  • 吉田 和生, 櫻井 準, 水野 裕也, 小出 真哉, 小田代 夏子, 新福 正機, 高橋 達一郎, 立野 玄一郎, 谷 英明, 堤 千紗, et al. 内因性うつ病と反応性うつ病で診療内容は異なるか 薬物療法、精神療法 精神科医502名を対象とした質問紙調査より. 精神神経学雑誌. 2011. 2011特別. S-216
Awards (8):
  • 2020/10 - 日本臨床精神神経薬理学会 学会奨励賞
  • 2020/03 - American Society of Clinical Psychopharmacology New Investigator Award
  • 2020/01 - American Psychiatric Association Junior Psychiatrist Research Colloquium
  • 2018/12 - American College of Neuropsychopharmacology Travel Award
  • 2018/06 - JSNP Excellent Presentation Award for CINP
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page